Cosmo Pharmaceuticals NV COSMO PHARMACEUTICALS ORD SHS
Cosmo Pharmaceuticals NV COSMO PH.../ NL0011832936 /
0RGI
|
5/24/2024 4:22:36 PM
|
Chg.
-
|
Volume |
Bid6:00:05 AM |
Ask6:00:05 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
71.90CHF
|
-
|
1,187
Turnover: 85,345.30 |
-Bid Size: - |
-Ask Size: - |
1.06 bill.CHF |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
0.07 EUR |
-93.23% |
| EPS Diluted: |
- EUR |
-93.23% |
| Revenues per Share: |
5.95 EUR |
-5.27% |
| Book Value per Share: |
26.25 EUR |
-6.60% |
| Cash Flow per Share: |
2.31 EUR |
6.89% |
| Dividend per Share: |
2.00 EUR |
108.33% |
| Total |
in mill. |
|
| Revenues: |
96.72 EUR |
-5.27% |
| Net Income: |
1.15 EUR |
-93.34% |
| Operating Cash Flow: |
37.60 EUR |
- |
| Cash and Cash Equivalents: |
50.28 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
972.12 |
767.61 |
| P/S Ratio: |
11.60 |
9.16 |
| P/BV ratio: |
2.63 |
2.08 |
| P/CF Ratio: |
29.85 |
23.57 |
| PEG: |
-10.43 |
-8.23 |
| Earnings Yield: |
0.10% |
0.13% |
| Dividend Yield: |
2.90% |
3.67% |
| Market Capitalization |
|
| Market Capitalization: |
1.06 bill. CHF |
820.6 mill. CHF |
| Free Float Market Cap.: |
- CHF |
- CHF |
| Market Cap. / Employee: |
3.41 mill. CHF |
2.65 mill. CHF |
| Shares Outstanding: |
16.26 mill. |
|
Profitability
| Gross Profit Margin: |
59.33% |
| EBIT Margin: |
12.64% |
| Net Profit Margin: |
1.19% |
| Return on Equity: |
0.27% |
| Return on Assets: |
0.21% |
Financial Strength
| Liquidity I / Cash Ratio: |
216.96% |
| Liquidity II / Quick Ratio: |
339.76% |
| Liquidity III / Current Ratio: |
441.16% |
| Debt / Equity Ratio: |
29.81% |
| Dynam. Debt / Equity Ratio: |
338.33% |
Efficiency
| Employees: |
310 |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
312,009.68 EUR |
| Net Income / Employee: |
3,700.00 EUR |
| Total Assets / Employee: |
1,787,032.26 EUR |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
